VRTX logo

VRTX

Profile

Full Name

Vertex Pharmaceuticals Incorporated

Ticker Symbol

VRTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 1991

Indexes

S&P 500,NASDAQ 100

Website

http://www.vrtx.com

Employees

6100

Key Details

Price

$459.62(+0.57%)

Market cap

$118.03B(Mega cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.02B(+11.66% YoY)

Annual EPS

-$2.08(-114.97% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $459.62
    VRTX price is $459.62

    30-Day Relative Volume

    0.57
    VRTX 30-day relative volume is 0.57

    Price Performance

    Price Today change

    +0.57%
    VRTX price is up +0.57% today

    Price YTD change

    +14.13%
    VRTX price is up +14.13% since January 1st

    Price 1-year change

    -2.27%
    VRTX price is down -2.27% year-on-year

    Price 3-year change

    +59.97%
    VRTX price is up +59.97% over the past 3 years

    Price Range

    Price All-time high

    $519.88
    VRTX price is currently -11.59% below its historical high of $519.88

    Price 3-year low

    $271.61
    VRTX price is currently +69.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $118.03B
    VRTX market capitalization is $118.03 billion

    Market cap 3-year change

    +60.45%
    VRTX market capitalization is up +60.45% over the past 3 years

    Market cap All-time high

    $133.92B
    VRTX market capitalization is currently -11.86% below its historical high of $133.92 billion

    Market cap sector rank

    98.53%
    VRTX market capitalization is higher than 98.53% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.47%
    VRTX shares outstanding is down -0.47% year-on-year

    Shares Outstanding 3-Year Change

    +0.3%
    VRTX shares outstanding is up +0.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.45
    VRTX beta is 0.45

    200-day SMA

    $463.65
    VRTX price is currently -0.87% below its 200-day simple moving average

    50-day SMA

    $453.70
    VRTX price is currently +1.30% above its 50-day simple moving average

    RSI

    57.62
    VRTX 14-day relative strength index is 57.62

    Volume

    0.57
    VRTX 30-day relative volume is 0.57

    ATR

    $9.32
    VRTX average true range is $9.32

    10-day Historical Volatility

    17.59%
    VRTX 10-day historical volatility is 17.59%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $11.02B
    VRTX annual revenue is $11.02 billion

    Revenue Analysts estimate

    $11.94B
    VRTX annual revenue is currently -7.70% lower than the consensus analysts' forecast

    Revenue 1-year change

    +11.66%
    VRTX annual revenue is up +11.66% year-on-year

    Revenue Sector rank

    94.58%
    VRTX annual revenue is higher than 94.58% of companies in Healthcare sector

    EPS

    EPS

    -$2.08
    VRTX annual earnings per share is -$2.08

    EPS Analysts estimate

    $18.00
    VRTX annual earnings per share is currently -111.56% lower than the consensus analysts' forecast

    EPS 1-year change

    -114.97%
    VRTX annual earnings per share is down -114.97% year-on-year

    EPS Sector rank

    38.14%
    VRTX annual earnings per share is higher than 38.14% of companies in Healthcare sector

    Profit

    Gross profit

    $9.49B
    VRTX annual gross profit is $9.49 billion

    Gross margin

    86.11%
    VRTX annual gross profit margin is 86.11%

    Operating profit

    $4.39B
    VRTX annual operating income is $4.39 billion

    Operating margin

    39.88%
    VRTX annual operating profit margin is 39.88%

    Net income

    -$535.60M
    VRTX annual net profit is -$535.60 million

    Net margin

    -4.86%
    VRTX annual net profit margin is -4.86%

    Expenses

    Total expenses

    $6.63B
    VRTX annual total expenses is $6.63 billion

    Operating expenses

    $5.09B
    VRTX annual total operating expenses is $5.09 billion

    Cost of goods sold

    $1.53B
    VRTX annual cost of goods sold is $1.53 billion

    Selling, general & administrative expenses

    $1.46B
    VRTX annual SGA is $1.46 billion

    Depreciation and amortization

    $207.20M
    VRTX annual depreciation & amortization is $207.20 million

    Interest expense

    $30.60M
    VRTX annual interest expense is $30.60 million

    Income tax

    $784.10M
    VRTX annual income tax is $784.10 million

    EBIT & EBITDA

    EBIT

    $279.10M
    VRTX annual earnings before interest & taxes is $279.10 million

    EBITDA

    $486.30M
    VRTX annual EBITDA is $486.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $22.53B
    VRTX annual total assets is $22.53 billion

    Non current assets

    $12.94B
    VRTX annual long term assets is $12.94 billion

    Current assets

    $9.60B
    VRTX annual total current assets is $9.60 billion

    Cash and cash equivalents

    $4.57B
    VRTX annual cash & cash equivalents is $4.57 billion

    Accounts receivable

    $1.61B
    VRTX annual accounts receivable is $1.61 billion

    Inventory

    $1.21B
    VRTX annual inventory is $1.21 billion

    Liabilities

    Total liabilities

    $6.12B
    VRTX annual total liabilities is $6.12 billion

    Long term liabilities

    $2.56B
    VRTX annual total long term liabilities is $2.56 billion

    Current liabilities

    $3.56B
    VRTX annual total current liabilities is $3.56 billion

    Accounts payable

    $413.00M
    VRTX annual accounts payable is $413.00 million

    Debt

    Total debt

    $1.75B
    VRTX annual total debt is $1.75 billion

    Total debt 1-year change

    +116.42%
    VRTX annual total debt is up +116.42% year-on-year

    Long term debt

    $1.66B
    VRTX annual long term debt is $1.66 billion

    Short term debt

    $92.30M
    VRTX annual short term debt is $92.30 million

    Equity & Capital

    Shareholders equity

    $16.41B
    VRTX annual stockholders equity is $16.41 billion

    Book value

    $16.41B
    VRTX annual book value is $16.41 billion

    Retained earnings

    $9.61B
    VRTX annual retained earnings is $9.61 billion

    Working capital

    $6.03B
    VRTX annual working capital is $6.03 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$492.60M
    VRTX annual cash flow from operations is -$492.60 million

    Cash from operations 1-year change

    -113.93%
    VRTX annual cash flow from operations is down -113.93% year-on-year

    Cash from investing

    -$3.77B
    VRTX annual cash flow from investing activities is -$3.77 billion

    Cash from investing 1-year change

    -20%
    VRTX annual cash flow from investing activities is down -20% year-on-year

    Cash from financing

    -$1.49B
    VRTX annual cash flow from financing activities is -$1.49 billion

    Cash from financing 1-year change

    -165.9%
    VRTX annual cash flow from financing activities is down -165.9% year-on-year

    CAPEX

    CAPEX

    $485.40M
    VRTX annual capital expenditures is $485.40 million

    CAPEX 1-year change

    +87.85%
    VRTX annual capital expenditures is up +87.85% year-on-year

    Free Cash Flow

    Free cash flow

    -$978.00M
    VRTX annual free cash flow is -$978.00 million

    Free cash flow 1-year change

    -129.83%
    VRTX annual free cash flow is down -129.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    86.11%
    VRTX annual gross profit margin is 86.11%

    Operating margin

    39.88%
    VRTX annual operating profit margin is 39.88%

    Net margin

    -4.86%
    VRTX annual net profit margin is -4.86%

    ROA & ROE

    ROA

    -2.37%
    VRTX annual return on assets is -2.37%

    ROE

    -3.15%
    VRTX annual return on equity is -3.15%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VRTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VRTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.15
    VRTX price to book ratio is 7.15

    PB ratio Sector rank

    85.42%
    VRTX price to book ratio is higher than 85.42% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.63
    VRTX price to sales ratio is 10.63

    PS ratio Sector rank

    78.57%
    VRTX price to sales ratio is higher than 78.57% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $115.00B
    VRTX enterprise value is $115.00 billion

    Enterprise value Sector rank

    98.18%
    VRTX enterprise value is higher than 98.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1535.43
    VRTX EV/EBITDA is -1535.43

    EV/EBITDA Sector rank

    0.17%
    VRTX EV/EBITDA is higher than 0.17% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.69
    VRTX annual current ratio is 2.69

    Quick ratio

    2.35
    VRTX annual quick ratio is 2.35

    Leverage

    Debt to equity

    0.00
    VRTX annual debt to equity ratio is 0.00

    Interest coverage ratio

    9.12
    VRTX annual interest coverage ratio is 9.12

    Risk & Stability

    Piotroski F-Score

    3
    VRTX piotroski f-score is 3

    Altman Z-Score

    13.01
    VRTX altman z-score is 13.01

    Analyst ratings

    Recent major analysts updates

    May 6, 25 Scotiabank
    Sector Perform
    May 6, 25 RBC Capital
    Sector Perform
    May 6, 25 Needham
    Hold
    May 6, 25 Morgan Stanley
    Equal-Weight
    May 6, 25 Leerink Partners
    Market Perform
    May 6, 25 JP Morgan
    Overweight
    May 6, 25 Cantor Fitzgerald
    Overweight
    Apr 1, 25 RBC Capital
    Sector Perform
    Mar 31, 25 B of A Securities
    Buy
    Feb 20, 25 RBC Capital
    Sector Perform

    Institutional Ownership

    Screeners with VRTX included

    US stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    • What is the ticker symbol for Vertex Pharmaceuticals Incorporated?
    • Does Vertex Pharmaceuticals Incorporated pay dividends?
    • What sector is Vertex Pharmaceuticals Incorporated in?
    • What industry is Vertex Pharmaceuticals Incorporated in?
    • What country is Vertex Pharmaceuticals Incorporated based in?
    • When did Vertex Pharmaceuticals Incorporated go public?
    • Is Vertex Pharmaceuticals Incorporated in the S&P 500?
    • Is Vertex Pharmaceuticals Incorporated in the NASDAQ 100?
    • Is Vertex Pharmaceuticals Incorporated in the Dow Jones?
    • When was Vertex Pharmaceuticals Incorporated's last earnings report?
    • When does Vertex Pharmaceuticals Incorporated report earnings?
    • Should I buy Vertex Pharmaceuticals Incorporated stock now?

    What is the ticker symbol for Vertex Pharmaceuticals Incorporated?

    The ticker symbol for Vertex Pharmaceuticals Incorporated is NASDAQ:VRTX

    Does Vertex Pharmaceuticals Incorporated pay dividends?

    No, Vertex Pharmaceuticals Incorporated does not pay dividends

    What sector is Vertex Pharmaceuticals Incorporated in?

    Vertex Pharmaceuticals Incorporated is in the Healthcare sector

    What industry is Vertex Pharmaceuticals Incorporated in?

    Vertex Pharmaceuticals Incorporated is in the Biotechnology industry

    What country is Vertex Pharmaceuticals Incorporated based in?

    Vertex Pharmaceuticals Incorporated is headquartered in United States

    When did Vertex Pharmaceuticals Incorporated go public?

    Vertex Pharmaceuticals Incorporated's initial public offering (IPO) was on July 24, 1991

    Is Vertex Pharmaceuticals Incorporated in the S&P 500?

    Yes, Vertex Pharmaceuticals Incorporated is included in the S&P 500 index

    Is Vertex Pharmaceuticals Incorporated in the NASDAQ 100?

    Yes, Vertex Pharmaceuticals Incorporated is included in the NASDAQ 100 index

    Is Vertex Pharmaceuticals Incorporated in the Dow Jones?

    No, Vertex Pharmaceuticals Incorporated is not included in the Dow Jones index

    When was Vertex Pharmaceuticals Incorporated's last earnings report?

    Vertex Pharmaceuticals Incorporated's most recent earnings report was on May 5, 2025

    When does Vertex Pharmaceuticals Incorporated report earnings?

    The next expected earnings date for Vertex Pharmaceuticals Incorporated is Aug 1, 2025

    Should I buy Vertex Pharmaceuticals Incorporated stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page